2026年全球即時分子診斷市場報告

近年來，照護現場分子診斷市場發展迅速，預計將從2025年的39.8億美元成長到2026年的45.8億美元，複合年成長率達15.0%。過去幾年的成長歸因於多種因素，例如感染疾病的日益普及、急診診斷檢測的擴展、對快速臨床決策支援的需求不斷成長、分子檢測技術的進步以及醫院對即時診斷技術的日益普及。

預計未來幾年，照護現場分子診斷市場將快速成長，到2030年市場規模將達到79.1億美元，複合年成長率（CAGR）為14.7%。預測期內的成長要素包括：居家分子檢測的普及率不斷提高、快速診斷基礎設施投資增加、呼吸系統和腫瘤檢測應用範圍擴大、雲端診斷平台的整合度不斷提高，以及對疾病早期檢測的日益重視。預測期內的主要趨勢包括：快速分子檢測平台的普及率不斷提高、對分散式診斷解決方案的需求不斷成長、自動化檢體處理技術的整合度不斷提高、症候群檢測項目的擴展，以及對快速獲得檢測結果的日益重視。

感染疾病和呼吸系統疾病的急劇增加預計將對照護現場分子診斷市場的成長起到關鍵的推動作用。由病毒或細菌病原體引起的呼吸道感染疾病會影響呼吸系統，通常透過咳嗽、打噴嚏或直接接觸傳播。目前有多種治療方法用於控制這些疾病，包括吸入器、口服藥物、靜脈注射療法以及支持及時準確治療的即時分子診斷解決照護現場。例如，根據英國衛生安全局的數據，2022年第40週至2023年第15週總合，英格蘭108家國民醫療服務體系（NHS）信託機構共報告了1681例與確診流感病例相關的加護病房（ICU）入院病例。與上一季相比，這數字大幅上升（2022年第39週，114家信託機構共通報182例住院病例，到2022年第39週上升至316例）。感染疾病和呼吸道疾病發病率的上升以及相關的死亡風險增加，正在推動對照護現場分子診斷解決方案的需求。

照護現場分子診斷市場的主要企業正致力於提供技術先進的解決方案，以增強其競爭優勢。這些公司正在採用新一代即時分子診斷技術，包括酵素免疫分析法(ELISA)、聚合酵素鏈鎖反應(PCR)、質譜 (MS)、原位雜合反應、頻譜核型成像、DNA 微陣列及相關技術，以及相關服務，並將其整合到照護現場照護現場設備中，旨在縮短分析時間並降低整體成本。例如，2023 年 5 月，總部位於美國的診斷公司 Sensible Diagnostics 發布了照護現場PCR 系統。該公司利用了 Curative 在 COVID-19 疫情期間累積的診斷經驗。 Sensible Diagnostics 迄今已進行了超過 200 萬次 COVID-19就地檢驗，並表示其 PCR 平台可在 10 分鐘內提供結果。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球即時分子診斷市場：吸引力評分與分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施和互聯生態系統
  • 人工智慧（AI）和自主人工智慧
• 主要趨勢
  • 快速分子檢測平台的應用日益廣泛
  • 對分散式診斷解決方案的需求日益成長
  • 自動化樣品處理的整合度不斷提高
  • 擴大症候群檢測小組
  • 更加重視快速見效

第5章 終端用戶產業市場分析

• 醫院
• 分散式檢查機構
• 居家照護提供者
• 老年人照護住宅
• 診斷診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球即時分子診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球即時分子診斷市場規模、比較及成長率分析
• 全球即時分子診斷市場表現：規模與成長，2020-2025年
• 全球即時分子診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 依產品
• 檢測方法和試劑盒、儀器和分析設備
• 透過使用
• 呼吸道感染疾病、胃腸道感染疾病、性行為感染感染（STI）、院內感染（HAI）、血流感染疾病及敗血症相關感染疾病
• 最終用戶
• 分散式檢查機構、醫院、居家醫療機構和輔助生活設施
• 按類型細分：檢測和試劑盒
• 核酸增幅檢查（NAAT）、快速診斷檢測、分子檢測試劑盒、試劑及耗材
• 按類型細分：儀器和分析設備
• 微流體裝置、照護現場分析裝置

第10章 區域與國家分析

• 全球即時分子診斷市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
• 全球即時分子診斷市場：國家、績效及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 即時分子診斷市場：競爭格局與市佔率（2024 年）
• 即時分子診斷市場：公司估值矩陣
• 即時分子診斷市場：公司概況
  • Abbott Laboratories
  • F Hoffmann La Roche Ltd
  • BioMerieux SA
  • Hologic Inc
  • Becton Dickinson and Company

第37章：其他領先和創新企業

• Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen NV, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年即時分子診斷市場：提供新機會的國家
• 2030年即時分子診斷市場：蘊藏新機會的細分市場
• 2030年即時分子診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Point-of-care (POC) molecular diagnostics are tests designed to detect specific nucleic acids in clinical specimens, including feces, saliva, urine, blood, and tissue. These diagnostics rely on identifying targeted portions of microbial genetic material, specifically DNA or RNA. Widely utilized in the healthcare sector, POC molecular diagnostics are granted emergency usage authorization to diagnose various diseases. These diagnostics are instrumental in detecting disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS).

The primary products and services in point-of-care molecular diagnostics include assays and kits, instruments and analyzers, and software and services. Assays and kits are equipment used to carry out analyses, especially in studying disease pathways. They are commonly employed for rapid and accurate diagnosis and monitoring of various diseases. Technologies such as reverse transcription-polymerase chain reaction (RT-PCR), in situ hybridization, and sequencing are utilized in POC molecular diagnostics for diagnosing diseases like respiratory diseases, hospital-acquired infections (HAIs), cancer/oncology, hepatitis, and hematology. Point-of-care molecular diagnostics are employed in decentralized labs, hospitals, home care, and assisted living healthcare facilities.

Tariffs are impacting the point-of-care molecular diagnostics market by increasing costs of imported reagents, microfluidic cartridges, analyzers, sensors, and semiconductor components. Healthcare systems in North America and Europe are most affected due to dependence on imported diagnostic hardware, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are raising test prices and influencing procurement decisions. However, they are also driving domestic manufacturing, regional reagent production, and localized development of cost-efficient POC molecular diagnostic platforms.

The point-of-care molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides point-of-care molecular diagnostics market statistics, including point-of-care molecular diagnostics industry global market size, regional shares, competitors with a point-of-care molecular diagnostics market share, detailed point-of-care molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care molecular diagnostics industry. This point-of-care molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care molecular diagnostics market size has grown rapidly in recent years. It will grow from $3.98 billion in 2025 to $4.58 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, expansion of emergency diagnostic testing, rising demand for rapid clinical decision support, improvements in molecular assay technologies, growing use of poc diagnostics in hospitals.

The point-of-care molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $7.91 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to increasing adoption of home-based molecular testing, rising investments in rapid diagnostics infrastructure, expansion of respiratory and oncology testing applications, growing integration of cloud-based diagnostic platforms, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of rapid molecular testing platforms, rising demand for decentralized diagnostic solutions, growing integration of automated sample processing, expansion of syndromic testing panels, enhanced focus on fast turnaround times.

The rapid increase in the prevalence of infectious and respiratory diseases is anticipated to play a significant role in supporting the growth of the point-of-care molecular diagnostics market. Respiratory infections, caused by viral or bacterial pathogens, affect the respiratory system and are commonly transmitted through coughing, sneezing, or direct physical contact. The management of these conditions involves a wide range of therapeutic approaches, including inhalers, oral drugs, intravenous therapies, and point-of-care molecular diagnostic solutions that support timely and accurate treatment. For example, in June 2024, according to the UK Health Security Agency, between week 40 of 2022 and week 15 of 2023, a total of 108 National Health Service trusts in England reported 1,681 critical care admissions linked to confirmed influenza cases. This represented a sharp rise compared with the previous season, which recorded 182 admissions across 114 trusts, increasing to 316 by week 39 of 2022. Therefore, the growing incidence of infectious and respiratory diseases, along with associated mortality risks, is driving demand for point-of-care molecular diagnostic solutions.

Major companies operating in the point-of-care molecular diagnostics market are concentrating on delivering technologically advanced solutions to reinforce their competitive positioning. These players are adopting next-generation point-of-care molecular diagnostic technologies and associated services, including enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), in situ hybridization, spectral karyotyping imaging, DNA microarrays, and related techniques, for integration into point-of-care devices with the objective of reducing analysis time and lowering overall costs. For example, in May 2023, Sensible Diagnostics, a United States-based diagnostics company, introduced a 10-minute point-of-care PCR system. The company is leveraging the expertise gained by Curative through its diagnostics operations during the COVID-19 pandemic. Sensible Diagnostics reported that it has conducted more than two million molecular point-of-care COVID-19 tests, and its PCR platform delivers results within a 10-minute timeframe.

In July 2024, Roche Holding AG, a Switzerland-based global healthcare company focused on developing medicines, treatments, and diagnostics, acquired LumiraDx Ltd. for an undisclosed amount. This acquisition is intended to enhance Roche Holding AG's diagnostics portfolio, improve access to decentralized healthcare solutions, and expand testing capabilities, especially in underserved regions. LumiraDx Ltd. is a UK-based diagnostic company that specializes in creating innovative point-of-care (POC) testing solutions.

Major companies operating in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, BioMerieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

North America was the largest region in the point-of-care molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The point-of-care (POC) molecular diagnostics market includes revenues earned by AAT, antigen, or antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-Of-Care Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point-of-care molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Assays And Kits; Instruments And Analyzers
• 2) By Application: Respiratory Infections; Gastrointestinal Infections; Sexually Transmitted Infections (STIs); Hospital-Acquired Infections (HAIs); Bloodstream and Sepsis-Related Infections
• 3) By End-User: Decentralized Labs; Hospitals; Home Care; Assisted Living Healthcare Facilities
• Subsegments:
• 1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs); Rapid Diagnostic Tests; Molecular Detection Kits; Reagents And Consumables
• 2) By Instruments And Analyzers: Microfluidic Devices; Point-of-Care Analyzers
• Companies Mentioned: Abbott Laboratories; F Hoffmann La Roche Ltd; BioMerieux SA; Hologic Inc; Becton Dickinson and Company; Siemens Healthineers AG; QuidelOrtho Corporation; Bio Rad Laboratories Inc; Qiagen N V; Biocartis Group NV; DiaSorin S p A; SD Biosensor Inc; Cue Health Inc; Visby Medical Inc; Binx Health Inc; Molbio Diagnostics Pvt Ltd; Credo Diagnostics Biomedical Pvt Ltd; Genetron Health; Mammoth Biosciences Inc; Seegene Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Point-Of-Care Molecular Diagnostics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Point-Of-Care Molecular Diagnostics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Point-Of-Care Molecular Diagnostics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Point-Of-Care Molecular Diagnostics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Rapid Molecular Testing Platforms
  • 4.2.2 Rising Demand For Decentralized Diagnostic Solutions
  • 4.2.3 Growing Integration Of Automated Sample Processing
  • 4.2.4 Expansion Of Syndromic Testing Panels
  • 4.2.5 Enhanced Focus On Fast Turnaround Times

5. Point-Of-Care Molecular Diagnostics Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Decentralized Laboratories
• 5.3 Home Care Providers
• 5.4 Assisted Living Healthcare Facilities
• 5.5 Diagnostic Clinics

6. Point-Of-Care Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point-Of-Care Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Point-Of-Care Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Point-Of-Care Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Point-Of-Care Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Point-Of-Care Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point-Of-Care Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point-Of-Care Molecular Diagnostics Market Segmentation

• 9.1. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Assays And Kits, Instruments And Analyzers
• 9.2. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections
• 9.3. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities
• 9.4. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Assays And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables
• 9.5. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Instruments And Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microfluidic Devices, Point-of-Care Analyzers

10. Point-Of-Care Molecular Diagnostics Market Regional And Country Analysis

• 10.1. Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point-Of-Care Molecular Diagnostics Market

• 11.1. Asia-Pacific Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point-Of-Care Molecular Diagnostics Market

• 12.1. China Point-Of-Care Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point-Of-Care Molecular Diagnostics Market

• 13.1. India Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point-Of-Care Molecular Diagnostics Market

• 14.1. Japan Point-Of-Care Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point-Of-Care Molecular Diagnostics Market

• 15.1. Australia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point-Of-Care Molecular Diagnostics Market

• 16.1. Indonesia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point-Of-Care Molecular Diagnostics Market

• 17.1. South Korea Point-Of-Care Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point-Of-Care Molecular Diagnostics Market

• 18.1. Taiwan Point-Of-Care Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point-Of-Care Molecular Diagnostics Market

• 19.1. South East Asia Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point-Of-Care Molecular Diagnostics Market

• 20.1. Western Europe Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point-Of-Care Molecular Diagnostics Market

• 21.1. UK Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point-Of-Care Molecular Diagnostics Market

• 22.1. Germany Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point-Of-Care Molecular Diagnostics Market

• 23.1. France Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point-Of-Care Molecular Diagnostics Market

• 24.1. Italy Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point-Of-Care Molecular Diagnostics Market

• 25.1. Spain Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point-Of-Care Molecular Diagnostics Market

• 26.1. Eastern Europe Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point-Of-Care Molecular Diagnostics Market

• 27.1. Russia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point-Of-Care Molecular Diagnostics Market

• 28.1. North America Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point-Of-Care Molecular Diagnostics Market

• 29.1. USA Point-Of-Care Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point-Of-Care Molecular Diagnostics Market

• 30.1. Canada Point-Of-Care Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point-Of-Care Molecular Diagnostics Market

• 31.1. South America Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point-Of-Care Molecular Diagnostics Market

• 32.1. Brazil Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point-Of-Care Molecular Diagnostics Market

• 33.1. Middle East Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point-Of-Care Molecular Diagnostics Market

• 34.1. Africa Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point-Of-Care Molecular Diagnostics Market Regulatory and Investment Landscape

36. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 36.1. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Point-Of-Care Molecular Diagnostics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Point-Of-Care Molecular Diagnostics Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F Hoffmann La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Hologic Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Point-Of-Care Molecular Diagnostics Market Other Major And Innovative Companies

• Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

38. Global Point-Of-Care Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point-Of-Care Molecular Diagnostics Market

40. Point-Of-Care Molecular Diagnostics Market High Potential Countries, Segments and Strategies

• 40.1 Point-Of-Care Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Point-Of-Care Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Point-Of-Care Molecular Diagnostics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer